Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolon, Inc.

John Ryals1, Kay Lawton, Daniel Stevens

  • 1Metabolon, Inc., 800 Capitola Drive, Suite 1, Durham, NC 27713, USA.

Pharmacogenomics
|July 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conflicts between the DNA replication and repair machineries promote cell death in Gram-positive bacteria.

Microbiology (Reading, England)·2025
Same author

Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphataemia (XLH) in the UK.

Calcified tissue international·2025
Same author

Organ and tumour dosimetry of <sup>177</sup>Lu-rhPSMA-10.1, a novel PSMA-targeted therapy: results from a Phase I trial.

European journal of nuclear medicine and molecular imaging·2025
Same author

Preclinical Evaluation of <sup>177</sup>Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

An Introduction to the Journal of Cardiopulmonary Rehabilitation and Prevention's Special Issue on Pulmonary Rehabilitation.

Journal of cardiopulmonary rehabilitation and prevention·2024
Same author

Detecting Alzheimer's Disease Stages and Frontotemporal Dementia in Time Courses of Resting-State fMRI Data Using a Machine Learning Approach.

Journal of imaging informatics in medicine·2024
Same journal

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Pharmacogenomics·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
See all related articles

Metabolon utilizes advanced metabolomics technology to identify and quantify small molecules in biological samples. This fee-for-service approach supports biomarker discovery across various industries, aiming for broad application in health sciences.

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Biotechnology

Background:

  • Metabolomics is crucial for biomarker discovery.
  • Measuring small molecules (<1500 Da) provides insights into cellular metabolism, diet, and environmental factors.
  • Existing methods require advanced analytical and data-processing tools.

Purpose of the Study:

  • To introduce Metabolon's proprietary technology for comprehensive small molecule analysis.
  • To enable fee-for-service biomarker discovery for pharmaceutical, biotechnology, and other industries.
  • To establish a standard technology for small molecule analysis in health and related sciences.

Main Methods:

  • Utilizing proprietary mLIMStrade mark system with advanced metabolomic software.
  • Employing automated data-processing tools with data-analysis and quality-control algorithms.

Related Experiment Videos

  • Converting raw mass-spectrometry data into identified and quantitated compounds.

    • Main Results:

    • The technology enables the measurement of a wide range of small molecules.
    • The mLIMStrade mark system facilitates automated data processing and compound identification.
    • Fee-for-service studies demonstrate application in diverse industries.

    Conclusions:

    • Metabolon's technology offers a robust platform for small molecule analysis and biomarker discovery.
    • The fee-for-service model supports collaborations and broad industry application.
    • The company aims to standardize metabolomic analysis for health and scientific applications.